Navigation Links
Measuring artery repair cells could become new heart disease test

A more accurate method for measuring blood levels of specialized cells that circulate in the bloodstream and repair damage to the arterial lining has been discovered by Duke University Medical Center cardiologists. These cells, known as endothelial progenitor cells (EPC), are produced in the bone marrow and travel to the site of arterial damage.

The researchers said that tests for EPCs could be used to assess a patient's degree of coronary artery disease or risks for suffering a heart attack, and they could become as routine as the cholesterol and lipid tests cardiologists now commonly use. Patients with lower levels of circulating EPCs would be less able to repair cardiac damage. Thus, they would be those with greater disease and at greater risk for a cardiac event, said the Duke cardiologists

Additionally, the researchers found that the EPC levels correlated with the degree of coronary artery disease. Patients with no coronary artery disease had about 70 percent more EPCs than those who had disease in several coronary vessels.

Recent Duke research has linked the progression of the artery-clogging disease atherosclerosis to the inability of EPCs to continuously repair damage to the arterial lining. Duke researchers have shown that -- while risk factors such as poor diet, smoking, high cholesterol levels and inactivity are important in the development of atherosclerosis --the disease progresses as the body's loses its intrinsic ability to repair and rejuvenate itself.

Current methods for measuring EPCs ?which can represent as few as one out of 10,000 cells in a given blood sample ?are subjective and time-consuming, the researchers said. As an indicator of EPC cell levels, the new method uses measurements of the amount of a detoxification enzyme, known as aldehyde dehydrogenase (ALDH), which is produced in high amounts by EPCs.

"Our studies have shown that using ALDH activity to determine the numbers of EPCs in a blood sample mi ght be a better method for identifying and measuring EPC levels in patients with heart disease than currently used methods," said Duke cardiologist Thomas Povsic, M.D. Povsic presented the results of the Duke research March 12, 2006, during the 55th annual scientific sessions of the American College of Cardiology in Atlanta.

"In order for the use of EPC to become practical in human patients, we need an assay that is quick, reliable and accurate," said Povsic. "Since there are so few EPCs circulating, we literally need a method that can find a needle in a haystack. Our tests so far measuring using ALDH activity to measure EPCs represents a novel approach to solving this problem.

"The paradigm of atherosclerosis is changing. In the past we only thought of the risk factors we could measure, such as cholesterol, lipids and some new markers like c-reactive protein," Povsic continued. "We're learning that atherosclerosis is a balancing act between damage and repair, and now we may have a test that gives us insight into the repair portion of the equation."

"If the results of this study are borne out, measuring EPCs could be a better test for defining an individual patient's risk for heart disease," Povsic said. "Theoretically, patients who are found to have low levels of EPCs would be those patients we may want to treat more aggressively."

ALDH is produced in high amounts by stem cells in the bone marrow as part of the process of maintaining the longer lifespans of these cells. Researchers have used ALDH assays to measure the number of stem cells in the bone marrow, so the team has extended this assay to detect levels of EPCs, which are progenitor cells in the blood which may repair one's arteries.

Current methods for measuring EPCs are conducted in the laboratory and are laborious and time-consuming, Povsic said. Researchers first remove all the immune system cells from a blood sample, then culture the remaining cells and then count individual of EPC colonies that grow. The new system permits researchers to gauge the number of EPCs based by identifying those cells with a high amount of ALDH activity.

The Duke researchers based their studies on analysis of blood samples taken from 229 patients who underwent a cardiac catheterization at Duke University Hospital. The researchers found a close relationship between the amount of coronary artery disease and levels of EPCs in the blood as determined using the ALDH test.


'"/>

Source:Duke University Medical Center


Related biology news :

1. Measuring the impact of post-genomics on Mediterranean populations
2. Measuring hormone cuts antibiotic use in half in pneumonia patients
3. Measuring Enzymes At End Of Cancer Pathway Predicts Outcome Of Tarceva, Taxol
4. Measuring hidden parasites in falciparum malaria
5. Columbia study shows widely used artery clearing device does not help patients during heart attack
6. Heart repair gets new muscle
7. Nano-bumps could help repair clogged blood vessels
8. New understanding of DNA repair may pave way to cancer treatments
9. Researchers pioneer new gene therapy technique using natural repair process
10. Circulating stem cells play small role in lung repair
11. Muscle repair: Making a good system better, faster; implications for aging, disease
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:5/16/2017)... --  Bridge Patient Portal , an enterprise patient ... Systems , an electronic medical record solutions developer ... a partnership to build an interface between the ... products, including Centricity Practice Solution (CPS), Centricity Business ... integrations will allow healthcare delivery networks using GE ...
(Date:4/17/2017)... , April 17, 2017 NXT-ID, Inc. (NASDAQ: ... announces the filing of its 2016 Annual Report on Form 10-K ... Commission. ... 10-K is available in the Investor Relations section of the Company,s ... the SEC,s website at http://www.sec.gov . 2016 Year ...
(Date:4/11/2017)... N.Y. , April 11, 2017 ... fingerprints, but researchers at the New York University ... College of Engineering have found that partial similarities ... security systems used in mobile phones and other ... thought. The vulnerability lies in the ...
Breaking Biology News(10 mins):
(Date:6/20/2017)... ... June 20, 2017 , ... ... board of directors has formed a Higher Education Entrepreneurship Advisory Committee to implement ... institution presidents and other high-ranking representatives from 35 higher education institutions across the ...
(Date:6/20/2017)... June 20, 2017  Kibow Biotech Inc., a pioneer ... the issuance of a new patent covering a unique ... the U.S. Patent and Trademark Office on May 23 ... the Buzz of Bio award in 2014 in ... developing non-drug approaches to chronic disease. Renadyl™, the first ...
(Date:6/20/2017)... CA (PRWEB) , ... June 20, 2017 , ... ... technology for discovery of antibody therapeutics from millions-diverse immune repertoires, announces launch of ... in San Diego, California. Dave Johnson, PhD, CEO of GigaGen, will present on ...
(Date:6/19/2017)... (PRWEB) , ... June 19, 2017 , ... Tunnell ... for over 50 years. One of the biggest challenges faced by life sciences, biotech ... regulatory affairs services team is Kati Abraham , who is well known in ...
Breaking Biology Technology: